Skip to content

Clinical Application of Er:YAG Dental Laser System

Clinical Application of Er:YAG Dental Laser System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04811144
Enrollment
129
Registered
2021-03-23
Start date
2017-12-08
Completion date
2019-10-29
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laser Therapy

Keywords

Er:YAG, dentistry

Brief summary

The study aim was to evaluate the effectiveness of Er:YAG dental laser treatment modality for cavity, sensitive teeth, abnormal frenum attachment and peri-implantitis.

Detailed description

There are four indications will be included in this plan. They are Cavity, Sensitive Teeth, Abnormal Frenum Attachment and Peri-implantitis. Each indication has different procedures which are listed as below: Cavity: history records, affected range check, X-ray&photo, treatment, pain index check, return visit check after two weeks. Sensitive Teeth: history records, sensitive check, X-ray&photo, treatment, pain index and effectiveness check, return visit check after two weeks. Abnormal Frenum Attachment: history records, abnormal position check, photo, cutting, pain index check, return visit check after three, five and seven days. Peri-implantitis: History records, measure periodontal pocket depth, anaerobes collect, X-ray, photo, CT, treatment, pain index check, return visit check after one week, two weeks, four weeks and three months, six months check the effectiveness and collect anaerobes during every return visit. In the last return visit, X-ray and CT would be included.

Interventions

DEVICEEr:YAG dental laser

To treat Cavity, Sensitive Teeth, Abnormal Frenum Attachment and Peri-implantitis by using Er:YAG Dental Laser system which manufactured by LightMed Dental Technology Corp

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages: 20 years and above。 * Patients are available for multiple follow-up visits for the duration of the study. * Having the mental ability to express informed consent. * Patients clinically diagnosed as having Cavity, Sensitive Teeth, Abnormal Frenum Attachment or Peri-implantitis.

Exclusion criteria

* Severe diabetes and chronic diseases are excluded. * CVA patients or the patients taking anti-rejection medicine and osteoporosis drugs for long-term should be excluded. * Patient who suffer from photodermatosis and photosensitive patients (photoallergic). * The health condition is not well after health education and physical therapy are excluded. * Surgery on patients with serious diseases of the hemopoietic system (such as haemophilia and leukaemia). * Malignant tumours, obligate precancerous tumours, hemangiomas. * Coronary heart disease and chronic obstructive pulmonary diseases are excluded. * Pregnant woman.

Design outcomes

Primary

MeasureTime frameDescription
pain indextwo weeksThe Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is based solely on the ability to perform activities of daily living (ADLs) and can be used for adults and children 10 years old or older
sensitive checktwo weeksThe dentist asked participants few questions about dental status. Do you feel sudden discomfort in your teeth when you drink hot or cold beverages you once considered normal?
Abnormal Frenum Attachmenta weekwound healing status
Probing depthsix monthsdentist measurement participant's probing depth the distance from the gingival margin to pocket base

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026